File Download

There are no files associated with this item.

  • Find it @ UNIST can give you direct access to the published full text of this article. (UNISTARs only)
Related Researcher

곽상규

Kwak, Sang Kyu
Kyu’s MolSim Lab @ UNIST
Read More

Views & Downloads

Detailed Information

Cited time in webofscience Cited time in scopus
Metadata Downloads

Full metadata record

DC Field Value Language
dc.citation.conferencePlace KO -
dc.citation.title 2020 Fall Meeting of The KSBM -
dc.contributor.author Jun Yong Oh -
dc.contributor.author Batakrishna Jana -
dc.contributor.author Go Eun Min -
dc.contributor.author Jin, Eunji -
dc.contributor.author Kwak, Sang Kyu -
dc.contributor.author Choe, Wonyoung -
dc.contributor.author Ryu, Ja-Hyoung -
dc.date.accessioned 2024-01-31T22:36:26Z -
dc.date.available 2024-01-31T22:36:26Z -
dc.date.created 2020-12-23 -
dc.date.issued 2020-11-06 -
dc.description.abstract In this study, we intended to advance the possibilities of a
Zr-MOF-based delivery platform by utilizing self-assembling
bonds between the MOF active site and various carboxyl groups
in functional shield proteins. Functional cloaking proteins such as
GST-Afb (HER2 and EGFR) are very stable, inhibit reactions with
other proteins and can be used for targeting. Such proteins can
stabilize the active site of the MOF and also act as a targeting
moiety. We effectively controlled the MOF surface via an intrinsic
reaction between the active site and recombinant proteins to
develop a targeted drug delivery platform. This study provides an
insight into the potential applications of Zr-MOFs in nanomedicine
and the future of the biointerface of MOFs.
-
dc.identifier.bibliographicCitation 2020 Fall Meeting of The KSBM -
dc.identifier.uri https://scholarworks.unist.ac.kr/handle/201301/77965 -
dc.publisher The Korean Society for Biomaterials -
dc.title Cloaking Protein Shield Zr-MOF Delivery Platform for Targeted Nanomedicine -
dc.type Conference Paper -
dc.date.conferenceDate 2020-11-05 -

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.